Skip to main content
Top
Published in: Rheumatology International 12/2014

Open Access 01-12-2014 | Original Article

Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis

Authors: Kalle Mattila, Frank Buttgereit, Risto Tuominen

Published in: Rheumatology International | Issue 12/2014

Login to get access

Abstract

Work disability remains a considerable problem for many patients with rheumatoid arthritis (RA). Morning stiffness is a symptom of RA associated with early retirement from work and with impaired functional ability. We aimed to explore the patient’s perception of the impact of morning stiffness on the working life of patients with RA. A survey was conducted in 11 European countries. Patients of working age, with RA for ≥6 months and morning stiffness ≥3 mornings a week, were interviewed by telephone using a structured questionnaire. Responses were assessed in the total sample and in subgroups defined by severity and duration of morning stiffness and by country. A total of 1,061 respondents completed the survey, 534 were working, 224 were retired and the rest were, i.e. homemakers and unemployed. Among the 534 working respondents, RA-related morning stiffness affected work performance (47 %), resulted in late arrival at work (33 %) and required sick leave in the past month (15 %). Of the 224 retired respondents, 159 (71 %) stopped working earlier than their expected retirement age, with 64 % giving RA-related morning stiffness as a reason. There was a differential impact of increasing severity and increasing duration of morning stiffness on the various parameters studied. There were notable inter-country differences in the impact of RA-related morning stiffness on ability to work and on retirement. This large survey showed that from the patient’s perspective, morning stiffness reduces the ability to work in patients with RA and contributes to early retirement.
Literature
1.
go back to reference Hallert E, Husberg M, Bemfort L (2012) The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990–2010: before and after introduction of biologic agents. Rheumatology 51:338–346PubMedCrossRef Hallert E, Husberg M, Bemfort L (2012) The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990–2010: before and after introduction of biologic agents. Rheumatology 51:338–346PubMedCrossRef
2.
go back to reference ter Wee MM, Lems WF, Usan H, Gulpen A, Boonen A (2012) The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 71:161–171PubMed ter Wee MM, Lems WF, Usan H, Gulpen A, Boonen A (2012) The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 71:161–171PubMed
3.
go back to reference Wolfe F, Allaire S, Michaud K (2007) The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 34:2211–2217PubMed Wolfe F, Allaire S, Michaud K (2007) The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 34:2211–2217PubMed
4.
5.
go back to reference Burton W, Morrison A, Maclean R, Ruderman E (2006) Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 56:18–27CrossRef Burton W, Morrison A, Maclean R, Ruderman E (2006) Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 56:18–27CrossRef
6.
go back to reference Neovius M, Simard JF, Askling J (2011) How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? Ann Rheum Dis 70:1010PubMedCrossRef Neovius M, Simard JF, Askling J (2011) How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? Ann Rheum Dis 70:1010PubMedCrossRef
7.
go back to reference Rantalaiho VM, Kautiainen H, Jäarvenpää S, Virta L, Pohjolainen T, Korpela M et al (2013) Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000–8. Ann Rheum Dis 72:672–677PubMedCrossRef Rantalaiho VM, Kautiainen H, Jäarvenpää S, Virta L, Pohjolainen T, Korpela M et al (2013) Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000–8. Ann Rheum Dis 72:672–677PubMedCrossRef
8.
go back to reference Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R et al (2010) Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 12:R42PubMedCentralPubMedCrossRef Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R et al (2010) Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 12:R42PubMedCentralPubMedCrossRef
9.
go back to reference Nikiphorou E, Guh D, Bansback N, Zhang W, Dixey J, Williams P et al (2012) Work disability rates in RA. Results from an inception cohort with 24 years follow-up. Rheumatology 51:385–392PubMedCrossRef Nikiphorou E, Guh D, Bansback N, Zhang W, Dixey J, Williams P et al (2012) Work disability rates in RA. Results from an inception cohort with 24 years follow-up. Rheumatology 51:385–392PubMedCrossRef
10.
go back to reference Sokka T, Kautiainen H, Mottonen T, Hannonen P (1999) Work disability in rheumatoid arthritis 10 years after diagnosis. J Rheumatol 26:1681–1685PubMed Sokka T, Kautiainen H, Mottonen T, Hannonen P (1999) Work disability in rheumatoid arthritis 10 years after diagnosis. J Rheumatol 26:1681–1685PubMed
11.
go back to reference Young A, Dixey J, Kulinskaya E, Cox N, Davies P, Devlin J et al (2002) Which patients stop working because of rheumatoid arthritis? Results of five years’ follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 61:335–340PubMedCentralPubMedCrossRef Young A, Dixey J, Kulinskaya E, Cox N, Davies P, Devlin J et al (2002) Which patients stop working because of rheumatoid arthritis? Results of five years’ follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 61:335–340PubMedCentralPubMedCrossRef
12.
go back to reference Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175–1183PubMedCentralPubMedCrossRef Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175–1183PubMedCentralPubMedCrossRef
13.
go back to reference Kobelt G (2007) Thoughts on the health economics of rheumatoid arthritis. Ann Rheum Dis 66:35–39CrossRef Kobelt G (2007) Thoughts on the health economics of rheumatoid arthritis. Ann Rheum Dis 66:35–39CrossRef
14.
go back to reference Lundkvist J, Kastäng F, Kobelt G (2011) The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 8(Suppl 2):S49–S60 Lundkvist J, Kastäng F, Kobelt G (2011) The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 8(Suppl 2):S49–S60
15.
go back to reference Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637PubMedCentralPubMedCrossRef Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637PubMedCentralPubMedCrossRef
16.
go back to reference Almoallim H, Kamil A (2013) Rheumatoid arthritis: should we shift the focus from ’treat to target’ to ’treat to work’? Clin Rheumatol 32:285–287PubMedCrossRef Almoallim H, Kamil A (2013) Rheumatoid arthritis: should we shift the focus from ’treat to target’ to ’treat to work’? Clin Rheumatol 32:285–287PubMedCrossRef
17.
go back to reference Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399–408PubMedCrossRef Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399–408PubMedCrossRef
18.
go back to reference Cutolo M, Straub RH (2008) Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autimmun Rev 7:223–228CrossRef Cutolo M, Straub RH (2008) Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autimmun Rev 7:223–228CrossRef
19.
go back to reference Yazici Y, Pincus T, Kautiainen H, Sokka T (2004) Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 31:1723–1726PubMed Yazici Y, Pincus T, Kautiainen H, Sokka T (2004) Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 31:1723–1726PubMed
20.
go back to reference Khan NA, Yazici Y, Calvo-Alen J, Dadoniene J, Gossec L, Hansen TM et al (2009) Reevaluation of the role of duration of morning stiffness in the association of rheumatoid arthritis activity. J Rheumatol 36:2435–2442PubMedCrossRef Khan NA, Yazici Y, Calvo-Alen J, Dadoniene J, Gossec L, Hansen TM et al (2009) Reevaluation of the role of duration of morning stiffness in the association of rheumatoid arthritis activity. J Rheumatol 36:2435–2442PubMedCrossRef
21.
go back to reference Iqbal I, Dasgupta B, Taylor P, Heron L, Pilling C (2012) Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis. J Med Econ 15:1192–1200PubMedCrossRef Iqbal I, Dasgupta B, Taylor P, Heron L, Pilling C (2012) Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis. J Med Econ 15:1192–1200PubMedCrossRef
22.
go back to reference Hazes JMW, Hayton R, Silman AJ (1993) A reevaluation of the symptom of morning stiffness. J Rheumatol 20:1138–1142PubMed Hazes JMW, Hayton R, Silman AJ (1993) A reevaluation of the symptom of morning stiffness. J Rheumatol 20:1138–1142PubMed
23.
go back to reference Vliet Vlieland TPM, Zwinderman AH, Breedveld FC, Hazes JMW (1997) Measurement of morning stiffness in rheumatoid arthritis clinical trials. J Clin Epidemiol 50(7):757–763PubMedCrossRef Vliet Vlieland TPM, Zwinderman AH, Breedveld FC, Hazes JMW (1997) Measurement of morning stiffness in rheumatoid arthritis clinical trials. J Clin Epidemiol 50(7):757–763PubMedCrossRef
24.
go back to reference Westhoff G, Buttgereit F, Gromnica-Ihle E, Zink A (2008) Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology 47:980–984PubMedCrossRef Westhoff G, Buttgereit F, Gromnica-Ihle E, Zink A (2008) Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology 47:980–984PubMedCrossRef
25.
go back to reference Meenan RF, Yelin EH, Henke CJ, Curtis DI, Epstein WV (1978) The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs. Arthritis Rheum 21:827–833PubMedCrossRef Meenan RF, Yelin EH, Henke CJ, Curtis DI, Epstein WV (1978) The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs. Arthritis Rheum 21:827–833PubMedCrossRef
26.
go back to reference Zhao FL, Xie F, Hu H, Li SC (2013) Transferability of indirect cost of chronic disease: a systematic review and meta-analysis. Pharmacoeconomics 31:501–508PubMedCrossRef Zhao FL, Xie F, Hu H, Li SC (2013) Transferability of indirect cost of chronic disease: a systematic review and meta-analysis. Pharmacoeconomics 31:501–508PubMedCrossRef
27.
go back to reference Søgaard R, Sørensen J, Linde L, Hetland ML (2010) The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis. Clinicoecon Outcomes Res 2:105–112PubMedCentralPubMedCrossRef Søgaard R, Sørensen J, Linde L, Hetland ML (2010) The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis. Clinicoecon Outcomes Res 2:105–112PubMedCentralPubMedCrossRef
28.
go back to reference Braakman-Jansen L, Taal E, Kuper I, van de Laar M (2012) Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and patients without RA. Rheumatology 51:354–361PubMedCrossRef Braakman-Jansen L, Taal E, Kuper I, van de Laar M (2012) Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and patients without RA. Rheumatology 51:354–361PubMedCrossRef
29.
go back to reference Wang PS, Beck A, Berglund P et al (2003) Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 45:1303–1311PubMedCrossRef Wang PS, Beck A, Berglund P et al (2003) Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 45:1303–1311PubMedCrossRef
30.
go back to reference da Silva JAP, Phillips S, Buttgereit F (2011) Impact of impaired morning function on the lives and wellbeing of patients with rheumatoid arthritis. Scand J Rheumatol 40(Suppl 125):6–11CrossRef da Silva JAP, Phillips S, Buttgereit F (2011) Impact of impaired morning function on the lives and wellbeing of patients with rheumatoid arthritis. Scand J Rheumatol 40(Suppl 125):6–11CrossRef
31.
go back to reference Phillips S, Dow L (2012) Impact of impaired morning function on quality of life in rheumatoid arthritis: results of an exploratory patient survey. Int J Clin Rheumatol 7:597–606CrossRef Phillips S, Dow L (2012) Impact of impaired morning function on quality of life in rheumatoid arthritis: results of an exploratory patient survey. Int J Clin Rheumatol 7:597–606CrossRef
32.
go back to reference Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M et al (2009) A mismatch between self-reported physical work load and the HAQ: early identification of rheumatoid arthritis patients at risk for loss of work productivity. Clin Exp Rheumatol 27:422–429PubMed Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M et al (2009) A mismatch between self-reported physical work load and the HAQ: early identification of rheumatoid arthritis patients at risk for loss of work productivity. Clin Exp Rheumatol 27:422–429PubMed
33.
go back to reference Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2:473–488PubMedCrossRef Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2:473–488PubMedCrossRef
Metadata
Title
Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis
Authors
Kalle Mattila
Frank Buttgereit
Risto Tuominen
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3040-0

Other articles of this Issue 12/2014

Rheumatology International 12/2014 Go to the issue